1-3 of 3
Julie Smith, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: A Large Real-Time Multi-Center Prospective Longitudinal Observational Study

Mohamed L. Sorror, MD MSc, Barry E. Storer, PhD, Aaron T. Gerds, MDMS, Bruno C. Medeiros, MD, Paul J Shami, MD, John P. Galvin, MDMS,MPH, Kehinde U. Adekola, MBBS,MS, Selina Luger, MD, Maria R. Baer, MD, David A. Rizzieri, MD, Tanya M. Wildes, MD MSCI, Eunice S. Wang, MD, Stefan Faderl, MD, Jamie L. Koprivnikar, MD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MDPhDMPH, Julie Smith, MD, Mitchell Garrison, MD, Kiarash Kojouri, MD, Jennifer E. Nyland, PhD, Rachelle R. Moore, BS, Sophie L. Fleuret, BS, Ylinne Lynch, MD, Pamela S. Becker, MD, Mary-Elizabeth M. Percival, MD MS, Brenda M. Sandmaier, MD, Frederick R. Appelbaum, MD, Elihu H. Estey, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 207.
https://doi.org/10.1182/blood-2018-99-113094
Published: 2018
Journal Articles

Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observational Study

Mohamed L. Sorror, MD MSc, Barry E. Storer, PhD, Aaron T. Gerds, MDMS, Bruno C. Medeiros, MD, Paul J Shami, MD, John P. Galvin, MDMS,MPH, Kehinde U. Adekola, MBBS,MS, Selina Luger, MD, Maria R. Baer, MD, David A. Rizzieri, MD, Tanya M. Wildes, MD MSCI, Eunice S. Wang, MD, Stefan Faderl, MD, Jamie L. Koprivnikar, MD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MDPhDMPH, Julie Smith, MD, Mitchell Garrison, MD, Kiarash Kojouri, MD, Jennifer E. Nyland, PhD, Rachelle R. Moore, BS, Sophie L. Fleuret, BS, Ylinne Lynch, MD, Pamela S. Becker, MD, Mary-Elizabeth M. Percival, MD, Brenda M. Sandmaier, MD, Frederick R. Appelbaum, MD, Elihu H. Estey, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1388.
https://doi.org/10.1182/blood-2018-99-112672
Published: 2018
Journal Articles

A Prospective Multicenter Phase II Study by the Puget Sound Oncology Consortium (PSOC) of Gemcitabine (G), Carboplatin (C), Dexamethasone (D), and Rituximab (R) in Patients with Relapsed/Refractory Lymphoma

Aj ay K Gopal, MD, Oliver W. Press, MD, PhD, Andrei Shustov, MD, Stephen Petersdorf, MD, Ted Gooley, PhD, Jasmine T. Daniels, MD, Mitchell Garrison, MD, George Gjerset, MD, Matthew Lonergan, MD, Anne Murphy, MD, Julie Smith, MD, John M. Pagel, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2585.
https://doi.org/10.1182/blood.V112.11.2585.2585
Published: 2008